Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 839710-38-2 | MDL No. : | MFCD09264263 |
Formula : | C11H19NO5 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | QVOPNRRQHPWQMF-QMMMGPOBSA-N |
M.W : | 245.27 | Pubchem ID : | 25419095 |
Synonyms : |
|
Num. heavy atoms : | 17 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.82 |
Num. rotatable bonds : | 5 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 64.26 |
TPSA : | 76.07 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.58 cm/s |
Log Po/w (iLOGP) : | 2.21 |
Log Po/w (XLOGP3) : | 0.3 |
Log Po/w (WLOGP) : | 0.72 |
Log Po/w (MLOGP) : | 0.22 |
Log Po/w (SILICOS-IT) : | 0.28 |
Consensus Log Po/w : | 0.74 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -1.22 |
Solubility : | 14.8 mg/ml ; 0.0603 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.46 |
Solubility : | 8.5 mg/ml ; 0.0347 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -0.52 |
Solubility : | 74.1 mg/ml ; 0.302 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 3.27 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
[ 761460-04-2 ]
(S)-tert-Butyl 3-(2-ethoxy-2-oxoethyl)morpholine-4-carboxylate
Similarity: 0.98
[ 104227-71-6 ]
(S)-tert-Butyl (5-oxotetrahydrofuran-3-yl)carbamate
Similarity: 0.87
[ 1257850-82-0 ]
(S)-2-(4-(tert-Butoxycarbonyl)morpholin-2-yl)acetic acid
Similarity: 0.84
[ 101555-60-6 ]
(R)-2-(1-(tert-Butoxycarbonyl)pyrrolidin-2-yl)acetic acid
Similarity: 0.84
[ 1257850-82-0 ]
(S)-2-(4-(tert-Butoxycarbonyl)morpholin-2-yl)acetic acid
Similarity: 0.84
[ 101555-60-6 ]
(R)-2-(1-(tert-Butoxycarbonyl)pyrrolidin-2-yl)acetic acid
Similarity: 0.84
[ 159749-28-7 ]
1-(tert-Butoxycarbonyl)azetidine-2-carboxylic acid
Similarity: 0.81
[ 51077-14-6 ]
(S)-1-(tert-Butoxycarbonyl)azetidine-2-carboxylic acid
Similarity: 0.81
[ 761460-04-2 ]
(S)-tert-Butyl 3-(2-ethoxy-2-oxoethyl)morpholine-4-carboxylate
Similarity: 0.98
[ 104227-71-6 ]
(S)-tert-Butyl (5-oxotetrahydrofuran-3-yl)carbamate
Similarity: 0.87
[ 1257850-82-0 ]
(S)-2-(4-(tert-Butoxycarbonyl)morpholin-2-yl)acetic acid
Similarity: 0.84
[ 101555-60-6 ]
(R)-2-(1-(tert-Butoxycarbonyl)pyrrolidin-2-yl)acetic acid
Similarity: 0.84
[ 761460-04-2 ]
(S)-tert-Butyl 3-(2-ethoxy-2-oxoethyl)morpholine-4-carboxylate
Similarity: 0.98
[ 1257850-82-0 ]
(S)-2-(4-(tert-Butoxycarbonyl)morpholin-2-yl)acetic acid
Similarity: 0.84
[ 1824327-48-1 ]
tert-Butyl 2-(1-aminoethyl)morpholine-4-carboxylate
Similarity: 0.79
[ 500789-41-3 ]
4-tert-Butyl 2-methyl morpholine-2,4-dicarboxylate
Similarity: 0.79